-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
From October 29th to 31st, the 16th International Conference on Genomics (ICG-16) with the theme of "omics and global cooperation" was successfully held in Qingdao
.
Winlink Technology Group and its wholly-owned subsidiary Yunsheng Data jointly attended the event.
Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech entitled "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", and collaborated with the world’s top scientists Industry leaders gathered to talk about technological innovation and industrialization application progress in life sciences
.
Promoting precision medicine and clinical scientific research innovation
with information technology As the rapid development of digital life technology has led to an explosive growth of data, biomedicine has entered the era of big data research
.
Researchers and practitioners in the life sciences are faced with multiple challenges such as data storage, data management, data mining and analysis, and the need for a new generation of information technology such as flexible and efficient IT infrastructure, data governance, AI and information security is particularly urgent
.
On October 29, at the ICG-16 "Tumor Precision Diagnosis and Treatment Big Data Forum", Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech on "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", analyzing biomedicine from multiple angles In-depth integration of innovative technologies and industrial applications with information technology, and share with the participants Ronglian's research progress and application results in the field of precision medicine
.
Hu Peng said, "As a leading domestic enterprise digital service provider, Winlink Technology Group has been deeply involved in the life sciences field for more than ten years.
Field customers provide integrated professional platforms and industry cloud services"
.
Products such as precision medical auxiliary diagnosis platform appeared at the booth and attracted attention
.
During the event, RONGLIAN BioCloud analysis SaaS platform RONGLIAN BioCloud, precision medical auxiliary diagnosis platform, data analysis private cloud platform, and bioinformatics analysis all-in-one machine and other outstanding products and solutions in the life sciences The Ronglian exhibition area was newly unveiled and attracted the attention of the guests.
Many experts, scholars and industry customers stopped at the booth for in-depth exchanges
.
In the field of biomedicine, Ronglian is based on life sciences, insists on independent R&D and innovation, has obtained dozens of independent intellectual property rights, has mature solutions and rich industry experience
.
At the same time, Ronglian has been deeply engaged in industry applications and has formed a number of characteristic solutions such as precision medicine, multi-omics big data, cryo-electron microscopy data analysis, medical and health big data, etc.
, which are provided for clinical hospitals, scientific research institutions, biomedical companies and universities Specialized products and services
.
Ronglian Technology Group established Yunsheng Data, a professional subsidiary of the biomedical industry in 2020, to fully deploy the biomedical information service field.
According to the needs of the industry and customers, it can provide combined products and solutions such as public cloud, private cloud, and all-in-one, covering The overall solution from cloud (public cloud) to edge (local privatization deployment) to end (integrated terminal application) empowers the innovation and development of the biomedical industry
.
At present, Yunsheng Data has formed leading technological advantages in the collection, storage, management and use of biological genetic data.
It has successfully served BGI, Nuohe Zhiyuan, Jiyinga, National Children’s Medical Center (Shanghai), Nearly a hundred industry customers such as West Lake University
.
In the future, Winlink will continue to leverage its own advantages, strengthen the in-depth integration of technology and industry, promote precision medicine and clinical scientific research innovation with information technology, provide more professional products and services to customers in the life sciences field, and help the industry develop vigorously
.
From October 29th to 31st, the 16th International Conference on Genomics (ICG-16) with the theme of "omics and global cooperation" was successfully held in Qingdao
.
Winlink Technology Group and its wholly-owned subsidiary Yunsheng Data jointly attended the event.
Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech entitled "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", and collaborated with the world’s top scientists Industry leaders gathered to talk about technological innovation and industrialization application progress in life sciences
.
Promoting precision medicine and clinical scientific research innovation
with information technology As the rapid development of digital life technology has led to an explosive growth of data, biomedicine has entered the era of big data research
.
Researchers and practitioners in the life sciences are faced with multiple challenges such as data storage, data management, data mining and analysis, and the need for a new generation of information technology such as flexible and efficient IT infrastructure, data governance, AI and information security is particularly urgent
.
On October 29, at the ICG-16 "Tumor Precision Diagnosis and Treatment Big Data Forum", Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech on "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", analyzing biomedicine from multiple angles In-depth integration of innovative technologies and industrial applications with information technology, and share with the participants Ronglian's research progress and application results in the field of precision medicine
.
Hu Peng said, "As a leading domestic enterprise digital service provider, Winlink Technology Group has been deeply involved in the life sciences field for more than ten years.
Field customers provide integrated professional platforms and industry cloud services"
.
Products such as precision medical auxiliary diagnosis platform appeared at the booth and attracted attention
.
During the event, RONGLIAN BioCloud analysis SaaS platform RONGLIAN BioCloud, precision medical auxiliary diagnosis platform, data analysis private cloud platform, and bioinformatics analysis all-in-one machine and other outstanding products and solutions in the life sciences The Ronglian exhibition area was newly unveiled and attracted the attention of the guests.
Many experts, scholars and industry customers stopped at the booth for in-depth exchanges
.
In the field of biomedicine, Ronglian is based on life sciences, insists on independent R&D and innovation, has obtained dozens of independent intellectual property rights, has mature solutions and rich industry experience
.
At the same time, Ronglian has been deeply engaged in industry applications and has formed a number of characteristic solutions such as precision medicine, multi-omics big data, cryo-electron microscopy data analysis, medical and health big data, etc.
, which are provided for clinical hospitals, scientific research institutions, biomedical companies and universities Specialized products and services
.
Ronglian Technology Group established Yunsheng Data, a professional subsidiary of the biomedical industry in 2020, to fully deploy the biomedical information service field.
According to the needs of the industry and customers, it can provide combined products and solutions such as public cloud, private cloud, and all-in-one, covering The overall solution from cloud (public cloud) to edge (local privatization deployment) to end (integrated terminal application) empowers the innovation and development of the biomedical industry
.
At present, Yunsheng Data has formed leading technological advantages in the collection, storage, management and use of biological genetic data.
It has successfully served BGI, Nuohe Zhiyuan, Jiyinga, National Children’s Medical Center (Shanghai), Nearly a hundred industry customers such as West Lake University
.
In the future, Winlink will continue to leverage its own advantages, strengthen the in-depth integration of technology and industry, promote precision medicine and clinical scientific research innovation with information technology, provide more professional products and services to customers in the life sciences field, and help the industry develop vigorously
.
From October 29th to 31st, the 16th International Conference on Genomics (ICG-16) with the theme of "omics and global cooperation" was successfully held in Qingdao
.
Winlink Technology Group and its wholly-owned subsidiary Yunsheng Data jointly attended the event.
Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech entitled "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", and collaborated with the world’s top scientists Industry leaders gathered to talk about technological innovation and industrialization application progress in life sciences
.
Promoting precision medicine and clinical scientific research innovation
with information technology As the rapid development of digital life technology has led to an explosive growth of data, biomedicine has entered the era of big data research
.
Researchers and practitioners in the life sciences are faced with multiple challenges such as data storage, data management, data mining and analysis, and the need for a new generation of information technology such as flexible and efficient IT infrastructure, data governance, AI and information security is particularly urgent
.
On October 29, at the ICG-16 "Tumor Precision Diagnosis and Treatment Big Data Forum", Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech on "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", analyzing biomedicine from multiple angles In-depth integration of innovative technologies and industrial applications with information technology, and share with the participants Ronglian's research progress and application results in the field of precision medicine
.
Hu Peng said, "As a leading domestic enterprise digital service provider, Winlink Technology Group has been deeply involved in the life sciences field for more than ten years.
Field customers provide integrated professional platforms and industry cloud services"
.
Products such as precision medical auxiliary diagnosis platform appeared at the booth and attracted attention
.
During the event, RONGLIAN BioCloud analysis SaaS platform RONGLIAN BioCloud, precision medical auxiliary diagnosis platform, data analysis private cloud platform, and bioinformatics analysis all-in-one machine and other outstanding products and solutions in the life sciences The Ronglian exhibition area was newly unveiled and attracted the attention of the guests.
Many experts, scholars and industry customers stopped at the booth for in-depth exchanges
.
In the field of biomedicine, Ronglian is based on life sciences, insists on independent R&D and innovation, has obtained dozens of independent intellectual property rights, has mature solutions and rich industry experience
.
At the same time, Ronglian has been deeply engaged in industry applications and has formed a number of characteristic solutions such as precision medicine, multi-omics big data, cryo-electron microscopy data analysis, medical and health big data, etc.
, which are provided for clinical hospitals, scientific research institutions, biomedical companies and universities Specialized products and services
.
Ronglian Technology Group established Yunsheng Data, a professional subsidiary of the biomedical industry in 2020, to fully deploy the biomedical information service field.
According to the needs of the industry and customers, it can provide combined products and solutions such as public cloud, private cloud, and all-in-one, covering The overall solution from cloud (public cloud) to edge (local privatization deployment) to end (integrated terminal application) empowers the innovation and development of the biomedical industry
.
At present, Yunsheng Data has formed leading technological advantages in the collection, storage, management and use of biological genetic data.
It has successfully served BGI, Nuohe Zhiyuan, Jiyinga, National Children’s Medical Center (Shanghai), Nearly a hundred industry customers such as West Lake University
.
In the future, Winlink will continue to leverage its own advantages, strengthen the in-depth integration of technology and industry, promote precision medicine and clinical scientific research innovation with information technology, provide more professional products and services to customers in the life sciences field, and help the industry develop vigorously
.
From October 29th to 31st, the 16th International Conference on Genomics (ICG-16) with the theme of "omics and global cooperation" was successfully held in Qingdao
.
Winlink Technology Group and its wholly-owned subsidiary Yunsheng Data jointly attended the event.
Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech entitled "Information Technology Platform Promotes Precision Medicine Business and Clinical Research Model Innovation", and collaborated with top scientists around the world.
Industry leaders gathered to talk about technological innovation and industrialization application progress in life sciences
.
Promoting precision medicine and clinical scientific research innovation
with information technology As the rapid development of digital life technology has led to an explosive growth of data, biomedicine has entered the era of big data research
.
Researchers and practitioners in the life sciences are faced with multiple challenges such as data storage, data management, data mining and analysis, and the need for a new generation of information technology such as flexible and efficient IT infrastructure, data governance, AI and information security is particularly urgent
.
On October 29, at the ICG-16 "Tumor Precision Diagnosis and Treatment Big Data Forum", Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech on "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", analyzing biomedicine from multiple angles In-depth integration of innovative technologies and industrial applications with information technology, and share the research progress and application results of Ronglian in the field of precision medicine with the guests
.
From October 29th to 31st, the 16th International Conference on Genomics (ICG-16) with the theme of "omics and global cooperation" was successfully held in Qingdao
.
Winlink Technology Group and its wholly-owned subsidiary Yunsheng Data jointly attended the event.
Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech entitled "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", and collaborated with the world’s top scientists Industry leaders gathered to talk about technological innovation and industrialization application progress in life sciences
.
Promote precision medicine and clinical research innovation with information technology
With the rapid development of digital life technology leading to the explosive growth of data, biomedicine has entered the era of big data research
.
Researchers and practitioners in the life sciences are faced with multiple challenges such as data storage, data management, data mining and analysis, and the need for a new generation of information technology such as flexible and efficient IT infrastructure, data governance, AI and information security is particularly urgent
.
On October 29, at the ICG-16 "Tumor Precision Diagnosis and Treatment Big Data Forum", Hu Peng, deputy general manager of Yunsheng Data, delivered a keynote speech on "Information Technology Platform Promoting Precision Medicine Business and Clinical Research Model Innovation", analyzing biomedicine from multiple angles In-depth integration of innovative technologies and industrial applications with information technology, and share the research progress and application results of Ronglian in the field of precision medicine with the guests
.
Hu Peng said, "As a leading domestic enterprise digital service provider, Winlink Technology Group has been deeply involved in the life sciences field for more than ten years.
Field customers provide integrated professional platforms and industry cloud services"
.
Products such as precision medical auxiliary diagnosis platform appeared at the booth and attracted attention
.
During the event, RONGLIAN BioCloud analysis SaaS platform RONGLIAN BioCloud, precision medical auxiliary diagnosis platform, data analysis private cloud platform, and bioinformatics analysis all-in-one machine and other outstanding products and solutions in the life sciences The Ronglian exhibition area was newly unveiled and attracted the attention of the guests.
Many experts, scholars and industry customers stopped at the booth for in-depth exchanges
.
In the field of biomedicine, Ronglian is based on life sciences, insists on independent R&D and innovation, has obtained dozens of independent intellectual property rights, has mature solutions and rich industry experience
.
At the same time, Ronglian has been deeply engaged in industry applications and has formed a number of characteristic solutions such as precision medicine, multi-omics big data, cryo-electron microscopy data analysis, medical and health big data, etc.
, which are provided for clinical hospitals, scientific research institutions, biomedical companies and universities Specialized products and services
.
Ronglian Technology Group established Yunsheng Data, a professional subsidiary of the biomedical industry in 2020, to fully deploy the biomedical information service field.
According to the needs of the industry and customers, it can provide combined products and solutions such as public cloud, private cloud, and all-in-one, covering The overall solution from cloud (public cloud) to edge (local privatization deployment) to end (integrated terminal application) empowers the innovation and development of the biomedical industry
.
At present, Yunsheng Data has formed leading technological advantages in the collection, storage, management and use of biological genetic data.
It has successfully served BGI, Nuohe Zhiyuan, Jiyinga, National Children’s Medical Center (Shanghai), Nearly a hundred industry customers such as West Lake University
.
In the future, Winlink will continue to leverage its advantages, strengthen the in-depth integration of technology and industry, promote precision medicine and clinical scientific research innovation with information technology, provide more professional products and services to customers in the life sciences field, and help the industry develop vigorously
.
Hu Peng said, "As a leading domestic enterprise digital service provider, Winlink Technology Group has been deeply involved in the life sciences field for more than ten years.
Field customers provide integrated professional platforms and industry cloud services"
.
Products such as precision medical auxiliary diagnosis platform appeared at the booth and attracted attention
.
During the event, RONGLIAN BioCloud analysis SaaS platform RONGLIAN BioCloud, precision medical auxiliary diagnosis platform, data analysis private cloud platform, and bioinformatics analysis all-in-one machine and other outstanding products and solutions in the life sciences The Ronglian exhibition area was newly unveiled and attracted the attention of the guests.
Many experts, scholars and industry customers stopped at the booth for in-depth exchanges
.
In the field of biomedicine, Ronglian is based on life sciences, insists on independent R&D and innovation, has obtained dozens of independent intellectual property rights, has mature solutions and rich industry experience
.
At the same time, Ronglian has been deeply engaged in industry applications and has formed a number of characteristic solutions such as precision medicine, multi-omics big data, cryo-electron microscopy data analysis, medical and health big data, etc.
, which are provided for clinical hospitals, scientific research institutions, biomedical companies and universities Specialized products and services
.
Ronglian Technology Group established Yunsheng Data, a professional subsidiary of the biomedical industry in 2020, to fully deploy the biomedical information service field.
According to the needs of the industry and customers, it can provide combined products and solutions such as public cloud, private cloud, and all-in-one, covering The overall solution from cloud (public cloud) to edge (local privatization deployment) to end (integrated terminal application) empowers the innovation and development of the biomedical industry
.
At present, Yunsheng Data has formed leading technological advantages in the collection, storage, management and use of biological genetic data.
It has successfully served BGI, Nuohe Zhiyuan, Jiyinga, National Children’s Medical Center (Shanghai), Nearly a hundred industry customers such as West Lake University
.
In the future, Winlink will continue to leverage its own advantages, strengthen the in-depth integration of technology and industry, promote precision medicine and clinical scientific research innovation with information technology, provide more professional products and services to customers in the life sciences field, and help the industry develop vigorously
.
The main report of "Building China's Pharmaceutical Innovation Ecosystem (2021-2025)" is officially releasedHelping China's pharmaceutical innovation power to build Jingli
Technology to build a full-course active management model for patients outside the hospital
